Skip to main content
Clinical Trials/CTRI/2020/08/027280
CTRI/2020/08/027280
Not yet recruiting
Phase 2

A study to evaluate the duration of post operative analgesia using nalbuphine or butorphanol as adjuvant to intrathecal 0.5% bupivacaine compared to 0.5% bupivacaine alone in lower segmemt cesarean section

SGRDIMSAR0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Sponsor
SGRDIMSAR
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
SGRDIMSAR

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients who are willing to undergo the study.
  • 2\.Patients undergoing elective LSCS
  • 3\.Patients American Society of Anesthesiology (ASA) Grade II

Exclusion Criteria

  • 1\.Patient refusal
  • 2\.Patient with Cardiorespiratory problems
  • 3\.Patient with Coagulopathy
  • 4\.Patient with Neurological disease
  • 5\.Patient with Psychological disease
  • 6\.Patient with Endocrine disease and allergy to used drugs
  • 7\.Contraindication to drugs.
  • 8\.Complicated pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials